Skip to main content

Publications by Anna Månberg



A. Månberg et al., "Altered perivascular fibroblast activity precedes ALS disease onset," Nature Medicine, vol. 27, no. 4, 2021.
J. Dillner et al., "Antibodies to SARS-CoV-2 and risk of past or future sick leave," Scientific Reports, vol. 11, no. 1, 2021.
J. Remnestål et al., "Association of CSF proteins with tau and amyloid beta levels in asymptomatic 70-year-olds," Alzheimer's Research & Therapy, vol. 13, no. 1, 2021.
A. Jernbom Falk et al., "Autoantibody profiles associated with clinical features in psychotic disorders," Translational Psychiatry, vol. 11, no. 1, 2021.
H. Alkharaan et al., "Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19 : A Complementary Approach to Population Surveys," Journal of Infectious Diseases, vol. 224, no. 3, pp. 407-414, 2021.
J. Remnestål et al., "Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers," Translational Neurodegeneration, vol. 9, no. 1, 2020.
D. Just et al., "Exploring autoantibody signatures in brain tissue from patients with severe mental illness," Translational Psychiatry, vol. 10, no. 1, 2020.
A. Häggmark et al., "A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection," Molecular & Cellular Proteomics, vol. 18, no. 3, pp. 461-476, 2019.
A.-L. Lind et al., "CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia," Journal of Pain Research, vol. 12, pp. 2875-2889, 2019.
M. Uhlén et al., "The human secretome," Science Signaling, vol. 12, no. 609, 2019.
M. Garranzo-Asensio et al., "Identification of prefrontal cortex protein alterations in Alzheimer's Disease," OncoTarget, vol. 9, no. 13, pp. 10847-10867, 2018.
E. P. Thelin et al., "Protein profiling in serum after traumatic brain injury in rats reveals potential injury markers," Behavioural Brain Research, vol. 340, pp. 71-80, 2018.
A. Zandian et al., "Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy," Journal of Proteome Research, vol. 16, no. 3, pp. 1300-1314, 2017.
P. E. Khoonsari et al., "Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease," PLOS ONE, vol. 11, no. 3, 2016.
A. Häggmark-Månberg et al., "Autoantibody targets in vaccine-associated narcolepsy," Autoimmunity, vol. 49, no. 6, pp. 421-433, 2016.
J. Remnestål et al., "CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease," PROTEOMICS - Clinical Applications, vol. 10, no. 12, pp. 1242-1253, 2016.
C. Fredolini et al., "Immunocapture strategies in translational proteomics," Expert Review of Proteomics, vol. 13, no. 1, pp. 83-98, 2016.
A. Häggmark, J. M. Schwenk and P. Nilsson, "Neuroproteomic profiling of human body fluids," PROTEOMICS - Clinical Applications, vol. 10, no. 4, pp. 485-502, 2016.
A. Häggmark et al., "Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis," American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 5, pp. 574-583, 2015.
S. Byström et al., "Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis," Journal of Proteome Research, vol. 13, no. 11, pp. 4607-4619, 2014.
F. E. Magraoui et al., "Developing new methods to answer old and new questions in neurodegenerative diseases," Proteomics, vol. 14, no. 11, pp. 1308-1310, 2014.
A. Häggmark et al., "Plasma profiling revelas three proteins associated to amyotrophic lateral sclerosis," Annals of Clinical and Translational Neurology, vol. 1, no. 8, pp. 544-553, 2014.
A. Häggmark et al., "Antibody-based profiling of cerebrospinal fluid within multiple sclerosis," Proteomics, vol. 13, no. 15, pp. 2256-2267, 2013.
B. Ayoglu et al., "Autoantibody profiling in multiple sclerosis using arrays of human protein fragments," Molecular & Cellular Proteomics, vol. 12, no. 9, pp. 2657-2672, 2013.
A. Häggmark et al., "Classification of protein profiles from antibody microarrays using heat and detergent treatment.," New Biotechnology, vol. 29, no. 5, pp. 564-570, 2011.
B. Ayoglu et al., "Systematic antibody and antigen-based proteomic profiling with microarrays," EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, vol. 11, no. 2, pp. 219-234, 2011.

Kapitel i böcker

E. Pin et al., "Array-based profiling of proteins and autoantibody repertoires in CSF," in Cerebrospinal Fluid (CSF) Proteomics, : Humana Press Inc., 2019, pp. 303-318.
A. Häggmark-Månberg, P. Nilsson and J. Schwenk, "Neuroproteomic profiling of cerebrospinal fluid (CSF) by multiplexed affinity arrays," in Neuroproteomics : Methods and Protocols, : Humana Press, 2017, pp. 247-254.

Icke refereegranskade


M. Persson et al., "Searching for Novel Autoantibodies with Clinical Relevance in Psychiatric Disorders," Schizophrenia Bulletin, vol. 44, pp. S120-S121, 2018.
D. Just et al., "Towards Molecular Insights Into Psychiatric Disorders Using Affinity Proteomics," Schizophrenia Bulletin, vol. 44, pp. S223-S223, 2018.


A. Häggmark, "Neuroproteomic profiling of human body fluids," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-BIO-Report, 2015:2, 2015.
Senaste synkning med DiVA:
2021-10-16 01:01:41